Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The reticuloendothelial system (RES), now largely synonymous with the mononuclear phagocyte system, is a network of phagocytic cells (monocytes, macrophages, and specialized endothelial cells) distributed throughout the body, especially in the liver, spleen, bone marrow, and lymph nodes. It plays a crucial role in phagocytosis, immune regulation, clearance of pathogens and cellular debris, and hematopoiesis support. Impaired RES function can be observed in various diseases and can be assessed using radiolabeled particle studies for clinical prognosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reticuloendothelial System (RES).